Drug
Insulin Degludec Liraglutide
Insulin Degludec Liraglutide: highest development phase Phase 3, developed by Novo Nordisk. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Novo Nordisk
Trials
| Drug | Phase | Indication |
|---|---|---|
| Insulin degludec/liraglutide NCT03172494 | Phase 3 | Diabetes |
Latest
No recent events.
Follow Insulin Degludec Liraglutide on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.